Dimensional Fund Advisors’s Soleno Therapeutics SLNO Stock Holding History

Dimensional Fund Advisors’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,102	Closed	-$548K	–	3311
2025 Q3	$548K	Buy	+8,102	New	+$601K	﹤0.01%	2981
2024 Q4	–	Sell	-4,522	Closed	-$228K	–	3362
2024 Q3	$228K	Buy	+4,522	New	+$216K	﹤0.01%	3149
2024 Q1	–	Sell	-20,754	Closed	-$835K	–	3429
2023 Q4	$835K	Hold	20,754	–	–	﹤0.01%	2958
2023 Q3	$612K	Sell	20,754 -4,212	-17%	-$25.5K	﹤0.01%	3021
2023 Q2	$107K	Sell	24,966 -5,173	-17%	-$22.2K	﹤0.01%	3312
2023 Q1	$64.5K	Buy	+30,139	New	+$67.7K	﹤0.01%	3365
2020 Q3	–	Sell	-3,374	Closed	-$112K	–	3357
2020 Q2	$112K	Hold	3,374	–	–	﹤0.01%	3267
2020 Q1	$120K	Hold	3,374	–	–	﹤0.01%	3260
2019 Q4	$149K	Hold	3,374	–	–	﹤0.01%	3280
2019 Q3	$76K	Hold	3,374	–	–	﹤0.01%	3364
2019 Q2	$142K	Hold	3,374	–	–	﹤0.01%	3359
2019 Q1	$104K	Hold	3,374	–	–	﹤0.01%	3376
2018 Q4	$87K	Hold	3,374	–	–	﹤0.01%	3367
2018 Q3	$109K	Buy	3,374 +416	+14%	+$15.1K	﹤0.01%	3351
2018 Q2	$104K	Buy	+2,958	New	+$86.7K	﹤0.01%	3299

Other funds holding SLNO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors's SLNO Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of Soleno Therapeutics (SLNO) in Q4 2025, closing a stake of 8,102 shares — an estimated $548K sold.

Dimensional Fund Advisors first reported a position in SLNO in Q2 2018 and held it in 15 quarters. The position peaked at $835K in Q4 2023. 248 funds tracked by Wall St. Rank hold SLNO as of Q4 2025.

Dimensional Fund Advisors reported no remaining Soleno Therapeutics position as of Q4 2025 after selling out during the quarter.
Dimensional Fund Advisors sold 8,102 Soleno Therapeutics shares in Q4 2025, an estimated $548K.
Dimensional Fund Advisors first reported a position in Soleno Therapeutics in Q2 2018 and held it in 15 quarters.
Dimensional Fund Advisors's Soleno Therapeutics position peaked at $835K in Q4 2023.
248 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.